FDA Inspection 1267654 — CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd.
The FDA completed an inspection of CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. on March 21, 2025 in Shijiazhuang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shijiazhuang (China)